Public Company News

ASX listed PharmAust has taken a major step towards safeguarding the intellectual property of its promising anti-cancer drug after being granted a key patent in China. The patent strengthens the Perth-based company’s IP protection in a critical world market and provides protection for 16 years, with PharmAust expecting further patents to be issued in coming months.

Stargroup’s remarkable transformation from small time ATM machine operator to a totally vertically integrated and ASX listed outfit with ownership up and down the value chain is now complete. The Indue acquistion came with a massive windfall for Stargroup after two large exiting clients agreed to resign and a Sydney credit provider forfeited $325k when they failed to provide financing. 

Blina Minerals have snapped up the Dingo gold project in the Eastern Goldfields for the bargain price of $20,000. The project comes with extensive historical drill data that has defined a significant zone of shallow mineralisation, with the real prize potentially being the primary source of mineralisation in an underlying intrusive body.

Medical device company Analytica has advanced its “PeriCoach” incontinence device by developing a proprietary exercise regime that can be integrated into the company’s e-health treatment system. PeriCoach is targeted at the millions of women worldwide who suffer from urinary incontinence, with the problem impacting around 1 in 3 women globally according to Analytica

Sky and Space Global have easily raised $10 million at 19c a share in a heavily oversubscribed placement that will fund the company as it forges ahead with the launch of its first three miniature telecommunications satellites within weeks. The company’s amazing share price run has seen the stock jump from a low of 1.6c in August last year to 26c last month.  

Pilbara Minerals now have offtake deals for 100% of Pilgangoora production, with a serious Chinese Lithium player committing to more than half of the project’s output for the next 10 years. Pilbara’s share price soared on news of the deal with Ganfeng Lithium, which has also promised at least $20m in funding support.

Lithium Australia’s focus on technology is paying dividends with the successful trial of a newly developed portable tool that is able to measure Lithium content from core samples in the field. The analyzer overcomes the limitations of the more traditional “XRF” tool that struggles to identify Lithium and could bring a whole new perspective to the feverish global hunt for Lithium.

MGC Pharmaceuticals has cemented its position in the Australian medical marijuana market, signing a major research agreement with the Royal Melbourne Institute of Technology. The deal will see MGC and RMIT collaborate on medical cannabis research initiatives targeted at a range of diseases including cancer and establish an “International Library of Cannabis Medicine”.

Medicinal marijuana player MGC Pharmaceuticals are on a mission to be one of the first ASX listed companies to garner serious revenues from medicinal cannabis derived products. The company announced this week they had signed up wholesalers in Europe to market their cannabis derived skin care and cosmetics lines. 

The Browns Range heavy rare earths project is moving ahead quickly following last month’s Final Investment Decision, with developer Northern Minerals striking a $10m mining agreement with MACA. The deal comes under Northern’s innovative lead contractor agreement with Sinosteel MECC, which allows deferred payment for 20% of all works.

Auroch Minerals are racing ahead with the first drill program at their high-impact Copper-Zinc project in Portugal, locking in a contractor to start drilling mid-month. The drill results will be hotly anticipated, with the project located just 20 km along strike from the “super-giant” Neves Corvo mine and sitting on a host of ripe geophysical targets.

ASX listed medical device company Analytica has refined its innovative PeriCoach urinary incontinence device, with the Brisbane-based company unveiling the latest version of its e-health treatment system. The version 3 device includes better processing capability, wireless connectivity, power management and an enhanced user experience.